Immunotherapy in type 1 diabetes: Novel pathway to the future ahead

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

104

Figures (1-3)

Tables (1-2)

Sum=127

Publishing Process of This Article

Item

Count

Browse

Download

Sum=3

Oct 15, 2024 (publication date) through Sep 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Diabetes. Oct 15, 2024; 15(10): 2022-2035
Published online Oct 15, 2024. doi: 10.4239/wjd.v15.i10.2022

Full Size Figure Download Figure

Figure 3 Key components of successful stem cell derived islet therapy for treating type 1 diabetes.

Citation: Ray S, Palui R. Immunotherapy in type 1 diabetes: Novel pathway to the future ahead. World J Diabetes 2024; 15(10): 2022-2035
URL: https://www.wjgnet.com/1948-9358/full/v15/i10/2022.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i10.2022